Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 17, 2004, Pages 2472-2477

  Hwang, Shinn Jang ^a,d   Luo, Jiing Chyuan ^b   Li, Chung Pin ^b   Chu, Cheng Wei ^b   Wu, Jaw Ching ^b   Lai, Chiung Ru ^a   Chiang, Jen Huei ^a   Chau, Gar Yang ^a   Lui, Wing Yiu ^a   Lee, Chun Chung ^c   Chang, Full Young ^b   Lee, Shou Dong ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d Section of Infectious Diseases   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA; THROMBOPOIETIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOASSAY; CANCER RECURRENCE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS; HEPATOBLASTOMA; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARANEOPLASTIC SYNDROME; PORTAL VEIN THROMBOSIS; PREDICTION; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR VOLUME; BLOOD; CROSS-SECTIONAL STUDY; LIVER TUMOR; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOCYTOSIS; THROMBOPOIETIN;

EID: 4444254762     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i17.2472     Document Type: Article

References (37)

1. Okuda K, Kondo Y. Primary carcinomas of the liver. In: Haubrich WS, Schaffner F, Berk JE, eds. Gastroenterology Volume 3.5th ed. Philadelphia: W. B. Saunders 1995: 2467-2468
2. Wu JC, Daughaday WH, Lee SD, Hsiao TSY, Chou CK, Lin HD, Tsai YT, Chiang BN. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med 1988; 112: 589-594
3. Hwang SJ, Lee SD, Chang CF, Wu JC, Tsay SH, Lui WY, Chiang JH, Lo KJ. Hypercholesterolemia in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 1992; 7: 491-496
4. Yen TC, Hwang SJ, Wang CC, Lee SD, Yeh SH. Hypercalcemia and parathyroid hormone-related protein in hepatocellular carcinoma. Liver 1993; 13: 311-315
5. Hwang SJ, Lee SD, Wu JC, Chang CF, Lu CL, Tsay SH, Lo KJ. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma. Chin Med J 1994; 53: 262-269
6. Luo JC, Hwang SJ, Li CP, Hsiao LT, Lai CR, Chiang JH, Lui WY, Chang FY, Lee SD. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer 1999; 86: 799-804
7. Nickerson HJ, Silberman TL, McDonald TP. Hepatoblastoma, thrombocytosis, and increased thrombopoietin. Cancer 1980; 45: 315-317
8. Shafford EA, Ritchard JP. Extreme thrombocytosis as a diagnostic clue to hepatoblastoma. Arch Dis Child 1993; 69: 171-174
9. Komura E, Matsumura T, Kato T, Tahara T, Tsunoda Y, Sawada T. Thrombopoietin in patients with hepatoblastoma. Stem Cells 1998; 16: 329-333
10. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B Jr, Solberg LA, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538
11. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Helpel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'hara PJ, Hagen FS, Roth GJ, Foster DC. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-568
12. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 1997; 89: 101-107
13. Nomura S, Ogami K, Kawamura K, Tsukamoto I, Kudo Y, Kanakura Y, Kitamura Y, Miyazaki H, Kato T. Cellular localization of thrombopoietin mRNA in the liver by in situ hybridization. Exp Hematol 1997; 25: 565-572
14. Martin TG, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997; 127: 285-288
15. Shimada Y, Kato T, Ogami K, Horie K, Kokubo A, Kudo Y, Maeda E, Sohma Y, Akahori H, Kawamura K, Miyazaki H. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995; 23: 1388-1396
16. Hino M, Nishizawa Y, Tagawa S, Yamane T, Morii H, Tatsumi N. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem Biophys Res Commun 1995; 217: 475-481
17. Pugh RN, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg 1973; 60: 646-649
18. Okuda K, Kondo Y. Primary carcinomas of the liver. In: Haubrich WS, Schaffner F, Berk JE, eds. Gastroenterology Volume 3.5th ed. Philadelphia: W. B. Saunders 1995: 2462-2463
19. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LighCycler™ a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-181
20. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668-3675
21. Nichol JL, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 1995; 95: 2973-2978
22. Cohen-Solal K, Villeval JL, Titeux M, Lok S, Vainchenker W, Wendling F. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 1996; 88: 2578-2584
23. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567-573
24. Emmons RV, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR. Human thrombopoietin levels are high when thrombocytopenia is due to increased platelet destruction. Blood 1996; 87: 4068-4071
25. Eaton DL, de Sauvage FJ. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 1997; 25: 1-7
26. Tahara T, Usuki K, Sato H, Ohashi H, Morita H, Tsumura H, Matsumoto A, Miyazaki H, Urabe A, Kato A. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematology 1996; 93: 783-788
27. Tomita N, Motomura S, Sakai R, Fujimaki K, Tanabe J, Fukawa H, Harano H, Kanamori H, Ogawa K, Mohri H, Marata A, Kodama F, Ishigatsubo Y, Tahara T, Kato T. Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia. Am J Hematol 2000; 63: 131-135
28. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gang A. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997; 27: 127-131
29. Sezai S, Kamisaka K, Ikegami F, Usuki M, Urabe A, Tahara T, Kato T, Miyazaki H. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol 1998; 93: 80-82
30. Wolber EM, Ganschow R, Burdelski M, Jelkmann W. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology 1999; 29: 1739-1742
31. Giannini E, Borro P, Botta F, Fumagalli A, Malfatti F, Podesta E, Romagnoli P, Testa E, Chiarbonello B, Polegato S, Mamone M, Testa R. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus related chronic hepatitis. J Hepatol 2002; 37: 572-577
32. Koruk M, Onuk MD, Akcay F, Savas MC. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Hepatogastroenterology 2002; 49: 1645-1648
33. Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999; 44: 754-758
34. Faeh M, Hauser SP, Nydegger UE. Transient thrombopoietin peak after liver transplantation for end stage liver disease. Br J Haematol 2001; 112: 493-498
35. Tsukahara A, Sato Y, Yamamoto S, Szuki S, Nakatsuka H, Watanabe T, Kameyama H, Hatakeyama K. Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation. Hepatogastroenterology 2003; 50: 227-230
36. Suva LJ, Winslow GA, Weltenhall RE, Hammonds RG, Moseley JM, Difenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987; 237: 893-896
37. Kew MC, Fisher JW. Serum erythropoietin concentrations in patients with hepatocellular carcinoma. Cancer 1986; 58: 2485-2488